Seed Therapeutics

King Of Prussia, United States

Seed Therapeutics is a biotech company that focuses on harnessing and engineering molecules.

$30.0M raised

Aug 2024

Series A

Biotechnology Medical Therapeutics

Top Investors

Eisai

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Seed Therapeutics

How much funding has Seed Therapeutics raised?

Seed Therapeutics has raised $30.0M in total funding. The most recent round was Series A. The last funding was announced in August 2024.

Who are Seed Therapeutics's investors?

Seed Therapeutics's investors include Eisai.

Where is Seed Therapeutics headquartered?

Seed Therapeutics is headquartered in King Of Prussia, United States.

What does Seed Therapeutics do?

Seed Therapeutics is a biotech company that focuses on harnessing and engineering molecules.

What stage is Seed Therapeutics at?

Seed Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 6, 2024.

MLA

"Seed Therapeutics — Funding & Investors." VCBacked, August 6, 2024, https://www.vcbacked.co/company/seed-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2024). Seed Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/seed-therapeutics

Wikipedia (cite web)

{{cite web |title=Seed Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/seed-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 6, 2024.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K